HEADER HYDROLASE 18-MAY-07 2PZG TITLE MINIMAL HUMAN CFTR FIRST NUCLEOTIDE BINDING DOMAIN AS A MONOMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CFTR NBD1 375-646(DEL405-436); COMPND 5 SYNONYM: CFTR, CAMP- DEPENDENT CHLORIDE CHANNEL, ATP-BINDING CASSETTE COMPND 6 TRANSPORTER SUB- FAMILY C MEMBER 7; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CFTR, ABCC7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON+RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: MODIFIED PET26B KEYWDS NBD, ABC TRANSPORTER, CFTR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.ATWELL,K.CONNERS,S.EMTAGE,T.GHEYI,N.R.GLENN,J.HENDLE,H.A.LEWIS, AUTHOR 2 F.LU,L.A.RODGERS,R.ROMERO,J.M.SAUDER,D.SMITH,H.TIEN,S.R.WASSERMAN, AUTHOR 3 X.ZHAO REVDAT 11 30-AUG-23 2PZG 1 REMARK SEQADV LINK REVDAT 10 14-NOV-18 2PZG 1 AUTHOR REVDAT 9 18-OCT-17 2PZG 1 REMARK REVDAT 8 16-AUG-17 2PZG 1 SOURCE REMARK REVDAT 7 13-JUL-11 2PZG 1 VERSN REVDAT 6 30-JUN-10 2PZG 1 JRNL REVDAT 5 24-FEB-09 2PZG 1 VERSN REVDAT 4 30-SEP-08 2PZG 1 REVDAT 3 26-AUG-08 2PZG 1 JRNL REVDAT 2 05-AUG-08 2PZG 1 REMARK REVDAT 1 09-OCT-07 2PZG 0 JRNL AUTH S.ATWELL,C.G.BROUILLETTE,K.CONNERS,S.EMTAGE,T.GHEYI, JRNL AUTH 2 W.B.GUGGINO,J.HENDLE,J.F.HUNT,H.A.LEWIS,F.LU, JRNL AUTH 3 I.I.PROTASEVICH,L.A.RODGERS,R.ROMERO,S.R.WASSERMAN, JRNL AUTH 4 P.C.WEBER,D.WETMORE,F.F.ZHANG,X.ZHAO JRNL TITL STRUCTURES OF A MINIMAL HUMAN CFTR FIRST NUCLEOTIDE-BINDING JRNL TITL 2 DOMAIN AS A MONOMER, HEAD-TO-TAIL HOMODIMER, AND PATHOGENIC JRNL TITL 3 MUTANT. JRNL REF PROTEIN ENG.DES.SEL. V. 23 375 2010 JRNL REFN ISSN 1741-0126 JRNL PMID 20150177 JRNL DOI 10.1093/PROTEIN/GZQ004 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.ATWELL,K.CONNERS,S.EMTAGE,T.GHEYI,H.LEWIS,F.LU,R.ROMERO, REMARK 1 AUTH 2 X.ZHAO REMARK 1 TITL STRUCTURE OF THE HUMAN CFTR NBD1 DOMAIN AS A HOMODIMER: REMARK 1 TITL 2 INSIGHTS AND APPLICATIONS REMARK 1 REF PEDIATR.PULMONOL.SUPPL. V. 30 100 2007 REMARK 1 REFN ISSN 1054-187X REMARK 1 PMID 17729305 REMARK 1 DOI 10.1002/PPUL.20699 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 47533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2389 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3344 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 250 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.76900 REMARK 3 B22 (A**2) : -0.12000 REMARK 3 B33 (A**2) : 0.88900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PZG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9796 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47606 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 24.909 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : 0.07700 REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.78100 REMARK 200 R SYM FOR SHELL (I) : 0.78100 REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2PZE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 9.5MG/ML NBD1, 0.15M NACL, REMARK 280 0.01M METHIONINE, 0.01M HEPES PH 7.5, 10% GLYCEROL, 0.001M TCEP, REMARK 280 0.002M ATP; WELL: 0.1M HEPES PH 6.5, 25% PEG 10K ; CRYO: 25% REMARK 280 GLYCEROL, VAPOR DIFFUSION, TEMPERATURE 281K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.20850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.65200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.74900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.65200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.20850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.74900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS A SINGLE DOMAIN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 374 REMARK 465 LEU A 375 REMARK 465 GLN A 376 REMARK 465 LYS A 377 REMARK 465 GLN A 378 REMARK 465 GLU A 379 REMARK 465 TYR A 380 REMARK 465 LYS A 381 REMARK 465 THR A 382 REMARK 465 LEU A 383 REMARK 465 GLU A 384 REMARK 465 TYR A 385 REMARK 465 ASN A 386 REMARK 465 LEU A 387 REMARK 465 THR A 388 REMARK 465 THR A 389 REMARK 465 LEU A 636 REMARK 465 GLN A 637 REMARK 465 SER B 374 REMARK 465 LEU B 375 REMARK 465 GLN B 376 REMARK 465 LYS B 377 REMARK 465 GLN B 378 REMARK 465 GLU B 379 REMARK 465 TYR B 380 REMARK 465 LYS B 381 REMARK 465 THR B 382 REMARK 465 LEU B 383 REMARK 465 GLU B 384 REMARK 465 TYR B 385 REMARK 465 ASN B 386 REMARK 465 GLU B 543 REMARK 465 GLY B 544 REMARK 465 GLY B 545 REMARK 465 GLN B 637 REMARK 465 PRO B 638 REMARK 465 ASP B 639 REMARK 465 PHE B 640 REMARK 465 SER B 641 REMARK 465 SER B 642 REMARK 465 LYS B 643 REMARK 465 LEU B 644 REMARK 465 MET B 645 REMARK 465 GLY B 646 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 LYS A 442 CG CD CE NZ REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 LYS A 481 CG CD CE NZ REMARK 470 LYS A 483 CG CD CE NZ REMARK 470 SER A 485 OG REMARK 470 LYS A 522 CD CE NZ REMARK 470 GLU A 528 CD OE1 OE2 REMARK 470 LYS A 532 CG CD CE NZ REMARK 470 GLU A 535 CG CD OE1 OE2 REMARK 470 LYS A 611 CE NZ REMARK 470 LYS A 612 CD CE NZ REMARK 470 ASN A 635 CG OD1 ND2 REMARK 470 GLU B 402 CG CD OE1 OE2 REMARK 470 GLU B 403 CG CD OE1 OE2 REMARK 470 LYS B 442 CD CE NZ REMARK 470 LYS B 481 CG CD CE NZ REMARK 470 LYS B 483 CD CE NZ REMARK 470 ARG B 518 CD NE CZ NH1 NH2 REMARK 470 LYS B 532 CG CD CE NZ REMARK 470 LYS B 584 CE NZ REMARK 470 LYS B 593 CD CE NZ REMARK 470 LYS B 611 CD CE NZ REMARK 470 LYS B 612 CE NZ REMARK 470 GLN B 634 CG CD OE1 NE2 REMARK 470 LEU B 636 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 391 -36.41 -130.96 REMARK 500 GLU A 403 82.64 -63.83 REMARK 500 LYS A 536 -140.74 55.47 REMARK 500 CYS A 590 -66.07 -95.57 REMARK 500 LYS A 593 -66.03 -96.40 REMARK 500 GLN A 634 -71.03 -69.20 REMARK 500 LYS B 536 -134.25 49.29 REMARK 500 TYR B 577 -3.40 74.44 REMARK 500 CYS B 590 -63.13 -96.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 7 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XMI RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F429S,F508A,H667R) REMARK 900 RELATED ID: 1XMJ RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F409L,F429S,F433L,DEL508,G550E,R553Q,R555K, REMARK 900 H667R) REMARK 900 RELATED ID: 2BB0 RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F409L,F429S,F433L,G550E,R553Q,R555K,H667R) REMARK 900 RELATED ID: 2BBS RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 '389-678'(F429S,F494N,DEL508,Q637R) REMARK 900 RELATED ID: 2BBT RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F494N,DEL508,Q637R) REMARK 900 RELATED ID: 1R0Z RELATED DB: PDB REMARK 900 MOUSE CFTR NBD1 389-673 REMARK 900 RELATED ID: 1R10 RELATED DB: PDB REMARK 900 MOUSE CFTR NBD1 389-673 REMARK 900 RELATED ID: 2IXE RELATED DB: PDB REMARK 900 HOMODIMER OF HUMAN TAP1 NBD(D645N) WITH ATP REMARK 900 RELATED ID: 1L2T RELATED DB: PDB REMARK 900 HOMODIMER OF METHANOCOCCUS JANNASCHII MJ0796(E171Q) REMARK 900 RELATED ID: 1Q12 RELATED DB: PDB REMARK 900 HOMODIMER OF E. COLI MALK REMARK 900 RELATED ID: 1XEF RELATED DB: PDB REMARK 900 HOMODIMER OF E. COLI HLYB NBD 467-707(H662A) REMARK 900 RELATED ID: 2HYD RELATED DB: PDB REMARK 900 HOMODIMER OF S. AUREUS ATP TRANSPORTER SAV1866 REMARK 900 RELATED ID: 2PZF RELATED DB: PDB REMARK 900 HUMAN NBD1 387-646(DEL 405-436, DEL 508) REMARK 900 RELATED ID: 2PZE RELATED DB: PDB REMARK 900 HUMAN NBD1 387-646(DEL 405-436) DBREF 2PZG A 375 404 UNP P13569 CFTR_HUMAN 375 404 DBREF 2PZG A 437 646 UNP P13569 CFTR_HUMAN 437 646 DBREF 2PZG B 375 404 UNP P13569 CFTR_HUMAN 375 404 DBREF 2PZG B 437 646 UNP P13569 CFTR_HUMAN 437 646 SEQADV 2PZG SER A 374 UNP P13569 EXPRESSION TAG SEQADV 2PZG SER B 374 UNP P13569 EXPRESSION TAG SEQADV 2PZG MET A 470 UNP P13569 VAL 470 VARIANT SEQADV 2PZG MET B 470 UNP P13569 VAL 470 VARIANT SEQRES 1 A 241 SER LEU GLN LYS GLN GLU TYR LYS THR LEU GLU TYR ASN SEQRES 2 A 241 LEU THR THR THR GLU VAL VAL MET GLU ASN VAL THR ALA SEQRES 3 A 241 PHE TRP GLU GLU GLY GLY THR PRO VAL LEU LYS ASP ILE SEQRES 4 A 241 ASN PHE LYS ILE GLU ARG GLY GLN LEU LEU ALA VAL ALA SEQRES 5 A 241 GLY SER THR GLY ALA GLY LYS THR SER LEU LEU MET MET SEQRES 6 A 241 ILE MET GLY GLU LEU GLU PRO SER GLU GLY LYS ILE LYS SEQRES 7 A 241 HIS SER GLY ARG ILE SER PHE CYS SER GLN PHE SER TRP SEQRES 8 A 241 ILE MET PRO GLY THR ILE LYS GLU ASN ILE ILE PHE GLY SEQRES 9 A 241 VAL SER TYR ASP GLU TYR ARG TYR ARG SER VAL ILE LYS SEQRES 10 A 241 ALA CYS GLN LEU GLU GLU ASP ILE SER LYS PHE ALA GLU SEQRES 11 A 241 LYS ASP ASN ILE VAL LEU GLY GLU GLY GLY ILE THR LEU SEQRES 12 A 241 SER GLY GLY GLN ARG ALA ARG ILE SER LEU ALA ARG ALA SEQRES 13 A 241 VAL TYR LYS ASP ALA ASP LEU TYR LEU LEU ASP SER PRO SEQRES 14 A 241 PHE GLY TYR LEU ASP VAL LEU THR GLU LYS GLU ILE PHE SEQRES 15 A 241 GLU SER CYS VAL CYS LYS LEU MET ALA ASN LYS THR ARG SEQRES 16 A 241 ILE LEU VAL THR SER LYS MET GLU HIS LEU LYS LYS ALA SEQRES 17 A 241 ASP LYS ILE LEU ILE LEU HIS GLU GLY SER SER TYR PHE SEQRES 18 A 241 TYR GLY THR PHE SER GLU LEU GLN ASN LEU GLN PRO ASP SEQRES 19 A 241 PHE SER SER LYS LEU MET GLY SEQRES 1 B 241 SER LEU GLN LYS GLN GLU TYR LYS THR LEU GLU TYR ASN SEQRES 2 B 241 LEU THR THR THR GLU VAL VAL MET GLU ASN VAL THR ALA SEQRES 3 B 241 PHE TRP GLU GLU GLY GLY THR PRO VAL LEU LYS ASP ILE SEQRES 4 B 241 ASN PHE LYS ILE GLU ARG GLY GLN LEU LEU ALA VAL ALA SEQRES 5 B 241 GLY SER THR GLY ALA GLY LYS THR SER LEU LEU MET MET SEQRES 6 B 241 ILE MET GLY GLU LEU GLU PRO SER GLU GLY LYS ILE LYS SEQRES 7 B 241 HIS SER GLY ARG ILE SER PHE CYS SER GLN PHE SER TRP SEQRES 8 B 241 ILE MET PRO GLY THR ILE LYS GLU ASN ILE ILE PHE GLY SEQRES 9 B 241 VAL SER TYR ASP GLU TYR ARG TYR ARG SER VAL ILE LYS SEQRES 10 B 241 ALA CYS GLN LEU GLU GLU ASP ILE SER LYS PHE ALA GLU SEQRES 11 B 241 LYS ASP ASN ILE VAL LEU GLY GLU GLY GLY ILE THR LEU SEQRES 12 B 241 SER GLY GLY GLN ARG ALA ARG ILE SER LEU ALA ARG ALA SEQRES 13 B 241 VAL TYR LYS ASP ALA ASP LEU TYR LEU LEU ASP SER PRO SEQRES 14 B 241 PHE GLY TYR LEU ASP VAL LEU THR GLU LYS GLU ILE PHE SEQRES 15 B 241 GLU SER CYS VAL CYS LYS LEU MET ALA ASN LYS THR ARG SEQRES 16 B 241 ILE LEU VAL THR SER LYS MET GLU HIS LEU LYS LYS ALA SEQRES 17 B 241 ASP LYS ILE LEU ILE LEU HIS GLU GLY SER SER TYR PHE SEQRES 18 B 241 TYR GLY THR PHE SER GLU LEU GLN ASN LEU GLN PRO ASP SEQRES 19 B 241 PHE SER SER LYS LEU MET GLY HET MG A 3 1 HET ATP A 1 31 HET GOL A 6 6 HET MG B 4 1 HET ATP B 2 31 HET GOL B 5 6 HET GOL B 7 6 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 MG 2(MG 2+) FORMUL 4 ATP 2(C10 H16 N5 O13 P3) FORMUL 5 GOL 3(C3 H8 O3) FORMUL 10 HOH *250(H2 O) HELIX 1 1 GLY A 463 MET A 472 1 10 HELIX 2 2 ILE A 502 PHE A 508 1 7 HELIX 3 3 ASP A 513 CYS A 524 1 12 HELIX 4 4 LEU A 526 LYS A 532 1 7 HELIX 5 5 GLU A 535 ASN A 538 5 4 HELIX 6 6 SER A 549 LYS A 564 1 16 HELIX 7 7 ASP A 579 CYS A 590 1 12 HELIX 8 8 LYS A 606 ALA A 613 1 8 HELIX 9 9 THR A 629 ASN A 635 1 7 HELIX 10 10 ASP A 639 MET A 645 5 7 HELIX 11 11 GLY B 463 MET B 472 1 10 HELIX 12 12 ILE B 502 PHE B 508 1 7 HELIX 13 13 ASP B 513 CYS B 524 1 12 HELIX 14 14 LEU B 526 SER B 531 1 6 HELIX 15 15 GLU B 535 ASN B 538 5 4 HELIX 16 16 SER B 549 LYS B 564 1 16 HELIX 17 17 ASP B 579 CYS B 590 1 12 HELIX 18 18 LYS B 606 ALA B 613 1 8 HELIX 19 19 THR B 629 ASN B 635 1 7 SHEET 1 A 3 LEU A 441 ILE A 448 0 SHEET 2 A 3 VAL A 392 ALA A 399 -1 N MET A 394 O PHE A 446 SHEET 3 A 3 GLU A 479 HIS A 484 -1 O LYS A 483 N VAL A 393 SHEET 1 B 6 ILE A 488 CYS A 491 0 SHEET 2 B 6 LEU A 568 ASP A 572 1 O LEU A 570 N CYS A 491 SHEET 3 B 6 ARG A 600 VAL A 603 1 O ILE A 601 N LEU A 571 SHEET 4 B 6 LEU A 453 ALA A 457 1 N LEU A 454 O LEU A 602 SHEET 5 B 6 LYS A 615 HIS A 620 1 O LEU A 617 N ALA A 455 SHEET 6 B 6 SER A 623 GLY A 628 -1 O PHE A 626 N ILE A 618 SHEET 1 C 2 GLY A 500 THR A 501 0 SHEET 2 C 2 VAL A 540 LEU A 541 -1 O LEU A 541 N GLY A 500 SHEET 1 D 3 LEU B 441 ILE B 448 0 SHEET 2 D 3 VAL B 392 ALA B 399 -1 N VAL B 397 O ILE B 444 SHEET 3 D 3 PRO B 477 LYS B 483 -1 O SER B 478 N THR B 398 SHEET 1 E 6 ILE B 488 CYS B 491 0 SHEET 2 E 6 LEU B 568 ASP B 572 1 O LEU B 570 N CYS B 491 SHEET 3 E 6 THR B 599 VAL B 603 1 O ILE B 601 N LEU B 571 SHEET 4 E 6 LEU B 453 ALA B 457 1 N VAL B 456 O LEU B 602 SHEET 5 E 6 LYS B 615 HIS B 620 1 O LEU B 619 N ALA B 457 SHEET 6 E 6 SER B 623 GLY B 628 -1 O PHE B 626 N ILE B 618 SHEET 1 F 2 GLY B 500 THR B 501 0 SHEET 2 F 2 VAL B 540 LEU B 541 -1 O LEU B 541 N GLY B 500 LINK C GLY A 404 N GLY A 437 1555 1555 1.34 LINK C GLY B 404 N GLY B 437 1555 1555 1.33 SITE 1 AC1 5 ATP A 1 THR A 465 GLN A 493 HOH A 647 SITE 2 AC1 5 HOH A 648 SITE 1 AC2 5 ATP B 2 THR B 465 GLN B 493 HOH B 647 SITE 2 AC2 5 HOH B 648 SITE 1 AC3 17 MG A 3 TRP A 401 VAL A 440 THR A 460 SITE 2 AC3 17 GLY A 461 ALA A 462 GLY A 463 LYS A 464 SITE 3 AC3 17 THR A 465 SER A 466 GLN A 493 HOH A 647 SITE 4 AC3 17 HOH A 648 HOH A 667 HOH A 692 HOH A 754 SITE 5 AC3 17 HOH A 765 SITE 1 AC4 19 MG B 4 TRP B 401 VAL B 440 THR B 460 SITE 2 AC4 19 GLY B 461 ALA B 462 GLY B 463 LYS B 464 SITE 3 AC4 19 THR B 465 SER B 466 GLN B 493 HOH B 647 SITE 4 AC4 19 HOH B 648 HOH B 674 HOH B 737 HOH B 740 SITE 5 AC4 19 HOH B 751 HOH B 757 HOH B 767 SITE 1 AC5 4 TYR B 577 TYR B 627 HOH B 655 HOH B 770 SITE 1 AC6 7 GLY A 551 GLN A 552 ARG A 555 LEU A 578 SITE 2 AC6 7 ASP A 579 HOH A 702 HOH A 715 SITE 1 AC7 8 SER B 489 TRP B 496 PHE B 508 ARG B 560 SITE 2 AC7 8 LYS B 564 HOH B 651 HOH B 659 HOH B 697 CRYST1 62.417 81.498 99.304 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016021 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012270 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010070 0.00000